Eric has been a scientist in the BioPharm industry since 1986 as a drug discovery scientist at Pfizer and AlphaBeta Technology and for over 20 years as a bioanalytical scientist at Biogen and Genentech. As a bioanalytical scientist, Eric led groups that specialized in the development, validation, and implementation of pharmacokinetic, immunogenicity, and biomarker asssays for multiple drug candidates. As an active participant in broad cross-functional project teams from early pre-IND phases through BLA submissions and post-marketing support, Eric has acquired a broad understanding of the drug development process. He has also interacted with Health Authorities via direct face-to-face interactions, as well as teleconferences and written query responses. Currently, Eric is a self-employed consultant to support bioanalytical strategies and review of assays development and data interpretation for a number of small companies.